Cancer cells often acquire a constitutively active nuclear factor-jB (NF-jB) program to promote survival, proliferation and metastatic potential by mechanisms that remain largely unknown. Extending observations from an immunologic setting, we demonstrate that microRNA146a and microRNA-146b (miR-146a/b) when expressed in the highly metastatic human breast cancer cell line MDA-MB-231 function to negatively regulate NF-jB activity. Lentiviral-mediated expression of miR-146a/b significantly downregulated interleukin (IL)-1 receptorassociated kinase and TNF receptor-associated factor 6, two key adaptor/scaffold proteins in the IL-1 and Tolllike receptor signaling pathway, known to positively regulate NF-jB activity. Impaired NF-jB activity was evident from reduced phosphorylation of the NF-jB inhibitor IjBa, reduced NF-jB DNA-binding activity and suppressed expression of the NF-jB target genes IL-8, IL-6 and matrix metalloproteinase-9. Functionally, miR-146a/b-expressing MDA-MB-231 cells showed markedly impaired invasion and migration capacity relative to control cells. These findings implicate miR146a/b as a negative regulator of constitutive NF-jB activity in a breast cancer setting and suggest that modulating miR-146a/b levels has therapeutic potential to suppress breast cancer metastases.
All unstimulated normal cell types, with the exception of B cells, maintain members of the nuclear factor-kB (NF-kB) family of transcription factors sequestered within inactive cytoplasmic complexes by the IkB inhibitor proteins (Bonizzi et al., 2004; Hoffmann and Baltimore, 2006) . NF-kB-activating signals, classically originating from members of the interleukin (IL)-1, Toll-like or tumor-necrosis factor receptor superfamily, promote the phosphorylation and proteasome-mediated degradation of IkB proteins, facilitating the release and nuclear translocation of NF-kB. This activation of NF-kB is typically transient and limited in magnitude by numerous negative feedback loops (Akira and Takeda, 2004; Bonizzi et al., 2004; Hayden and Ghosh, 2004; Hoffmann and Baltimore, 2006) . However, it has been realized for some time that many cancers have acquired a constitutively active NF-kB program, functioning to promote such features as their proliferation, survival, angiogenesis and metastasis (Karin, 2006; Van Waes, 2007; Sethi et al., 2008) .
The mechanisms underlying constitutive NF-kB activity in cancer cells remain poorly understood, although the signal transduction pathway producing classical NF-kB activation has been extensively studied (Bonizzi et al., 2004; Hoffmann and Baltimore, 2006; Van Waes, 2007; Sethi et al., 2008) . In this regard, IRAK1 (IL-1 receptor-associated kinase) and TRAF6 (tumour-necrosis factor receptor-associated factor 6), two linearly linked adaptor/scaffold components coupling signals originating from the IL-1 and the Toll-like receptor superfamily to NF-kB activation (Cao et al., 1996a, b; Taganov et al., 2007) , were recently proposed to be targeted by microRNA-146a and microRNA-146b (miR-146a/b) as part of an NF-kB-induced negative feedback loop in stimulated monocytes (Taganov et al., 2006 (Taganov et al., , 2007 Sonkoly et al., 2008) . In addition, a recent study has implicated the loss of miR-146a expression in the progression of hormone-refractory prostate cancer (Lin et al., 2008) . Given the ability of microRNAs (miRs) to orchestrate cellular functions by modulating the level of their targeted proteins by either translational arrest or transcript degradation, a capacity often deregulated in cancers by aberrant miR expression (Bartel, 2004; Karres et al., 2007; Ma et al., 2007) , we were prompted to evaluate the consequences of miR146a/b expression in human breast cancer cells where constitutive NF-kB activity has been associated with aggressive breast cancer clinical behavior (Zhou et al., 2005) .
The highly metastatic breast cancer cell line MDA-MB-231 with its constitutively active NF-kB program was infected with miR-146a, miR-146b and control viruses following lentivirus production as previously described (Coppe et al., 2006) . Viral titers were adjusted to yield similar expression levels of the two miRs, as judged by northern analysis shown in Figure 1a . The miR-146b probe showed some cross-hybridization to miR-146a (Figure 1a , right panel) as expected from their sequences (Taganov et al., 2006) . The lentiviruses expressed 10-to 30-fold higher levels of miR-146a or miR-146b relative to the low endogenous level of miR146a/b in control infected cells.
Evaluating the impact of ectopically expressed miR146a and miR-146b on IRAK1 protein levels, Figure 1b shows that miR-146a/b-expressing cells had IRAK1 levels reduced to approximately 25% of control levels. To determine whether this reduced IRAK1 protein level was accompanied by a corresponding suppression of IRAK1 mRNA, northern analysis was performed. As shown in Figure 1c , miR-146a/b-expressing and control MDA-MB-231 cells had essentially identical IRAK1 mRNA levels, suggesting that miR-146a/b suppressed IRAK1 mRNA translation but did not promote IRAK1 mRNA decay in these cells. The miR-146a/b expression also suppressed TRAF6 protein levels, although to a lesser extent (B40%) than IRAK1 protein suppression ( Figure 1d ).
As IRAK1 and TRAF6 are essential components of the Toll-like and IL-1 receptor signaling networks that activate NF-kB, the consequences of their suppression by miR-146a/b in MDA-MB-231 cells were examined. Phosphorylation of IkBa is a key measure of NF-kB activation. As shown in Figure 2a , although total protein levels of both IkBa and the NF-kB p65/Rel A component were similar between miR-146a/b-expressing and control MDA-MB-231 cells, phosphorylation of IkBa on serine 32, which is essential for its degradation, was reduced to approximately 40% and 20% of control levels in miR-146a and miR-146b cells, respectively.
To assess NF-kB transcriptional activity, nuclear extracts prepared from miR-146a/b-expressing and control cells were measured for NF-kB binding to a consensus NF-kB response element by electrophoretic mobility shift assays. Control nuclear extracts possessed approximately three-to four-fold greater NF-kB DNAbinding activity compared to nuclear extracts from miR146a/b-expressing cells ( Figure 2b , left panel). The identity of the shifted band as the p65/p50 heterodimer, the predominate form of the dimeric NF-kB transcriptional complex, was confirmed by antibodies to these proteins that supershifted the NF-kB band relative to a control antibody that had no influence on the band mobility ( Figure 2b , right panel). To confirm that the nuclear extracts contained equal amounts of protein, they were analysed by western blotting for histone deacetylase 2, an abundant and salt-extractable nuclear protein ( Figure 2b , bottom panel). Taken together, these results indicate that miR-146a/b expression significantly reduced NF-kB activity in these human breast cancer cells.
Consequences of the reduced level of NF-kB activity in miR-146a/b-expressing MDA-MB-231 cells were assessed by determining the expression level of NF-kB target genes contributing to the aggressive phenotype of these cells. As shown in Figure 3a , northern analysis of IL-8, a cytokine upregulated in many aggressive breast cancer cells (Benoy et al., 2004) , demonstrated a significant mRNA reduction (B70%) in miR-146a/bexpressing MDA-MB-231 cells compared to control Northern blot was performed as previously described (Scott et al., 2007) . Mature and pre-miRNA species are noted. RNA loading was confirmed by probing for the small RNA species, U6 RNA (bottom panel). The lentiviral miR-146a/b expression vectors were constructed by cloning 146 bp of pri miR-146a sequence and 120 bp of pri miR-146b sequence that included the terminal loop, the upper stem and the lower stem with 10 bp of upstream/downstream flanking genomic sequence into a site under cytomegalovirus promoter control. (b) Western blot of total protein lysates prepared from MDA-MB-231 cell pools as described in Figure 1a was probed for IRAK1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The ratio of IRAK1 to b-actin band intensity for each lysate was normalized to the control ratio as shown below the western panel. (c) Northern blot using total RNA isolated from MDA-MB-231 cells as described in (a) was probed for IRAK1. Reprobing the blot for GAPDH established equal RNA loading. The IRAK1 3.2-kb transcript size was deduced from the ethidium-stained gel 18S (1.9 kb) and 28S (5.0 kb) bands. (d) Western blot of total protein lysates as described in (b) was probed for TRAF6 (sc-7221; Santa Cruz Biotechnology). GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IRAK1, IL-1 receptor-associated kinase; miRNA, microRNA; TRAF6, tumour-necrosis factor receptor-associated factor 6.
Suppression of NF-jB activity in cancer cells by miR-146 D Bhaumik et al cells. Examination of conditioned medium by western blotting showed that miR-146a/b expression reduced secreted IL-8 levels by B75% relative to control levels ( Figure 3b) . Likewise, western analysis of conditioned media for NF-kB responsive proteins IL-6 and the metalloproteinase MMP-9 demonstrated significantly reduced expression in miR-146a/b-expressing cells relative to control cells, as shown in Figure 3b . Equal loading was established by normalization to IGFBP3 levels, a secreted protein with no reported dependence on NF-kB activation.
Given that NF-kB activity is known to enhance the survival and metastatic potential of cancer cells (Karin, 2006; Van Waes, 2007; Sethi et al., 2008) , the functional consequences of NF-kB suppression in miR-146a/ b-expressing MDA-MB-231 cells were explored using cell motility and Matrigel invasion assays under conditions of serum starvation. Typical fields from the Matrigel invasion assays, shown in Figure 4a , demonstrate that the ability to invade a basement membrane was significantly compromised in the miR-146a and miR146b cells relative to control cells. Quantifying these results, it was shown that the miR-146a-and miR-146b-overexpressing cells respectively possessed only 25% and 20% invasion capacity relative to control cells (Figure 4b) . In a migration assay experiment, miR-146a/ b-expressing cells displayed only 45% and 38% of control migration capacity, respectively (Figure 4c) . Interestingly, although compromised in their motility and invasiveness, the miR-146a/b-overexpressing cells exhibited no proliferation impairment or apoptosis sensitivity relative to control cells (data not shown), a result consistent with previous studies demonstrating that NF-kB activation does little to alter the proliferative or apoptotic index of MDA-MB-231 cells (Monks and Pardee, 2006; Zheng et al., 2006) .
The human breast cancer cell line MDA-MB-231 has been extensively used to study essential components of the metastatic process (Sliva et al., 2002; Cicek et al., 2005; Monks and Pardee, 2006; Zheng et al., 2006) . Results presented here demonstrate that ectopic expression of miR-146a/b in this cell line sharply curtailed NFkB activity and significantly reduced its ability to invade a basement membrane-like extracellular matrix, a key EMSA for binding to a consensus NF-kB DNA oligo probe using control (C), miR-146a (146a) and miR-146b (146b) nuclear extracts loaded in duplicate lanes (left panel). The position of the gel origin, NF-kB gel shifted band and free probe are indicated. Right panel shows specificity of NF-kB DNA binding as antibodies to the p65 and p50 subunits of NF-kB supershifted the NF-kB band (p65 Ab and p50 Ab lanes) whereas a control antibody (con Ab, an estrogen receptor antibody) had no effect. Bottom panel: western blot of nuclear extracts used for EMSA probed for HDAC2 (Santa Cruz Biotechnology) shows equal protein content of the extracts. HDAC2, histone deacetylase 2; miR, microRNA; NF-kB, nuclear factor-kB; EMSA, electrophoretic gel shift assays.
Suppression of NF-jB activity in cancer cells by miR-146 D Bhaumik et al event in cancer metastasis. Although this observed reduction in MDA-MB invasiveness likely derives in large part from miR-146a/b-targeted suppression of the upstream NF-kB signaling proteins IRAK1 and TRAF6, suppression of additional miR-146a/b targets, reflecting the well-known pleiotropic nature of miRs (Bartel, 2004) , would be anticipated to contribute to this altered metastatic phenotype. Preliminary studies using IkB-a siRNA to suppress a proximal negative regulator of NF-kB activity demonstrated that while restoring the invasiveness of miR-146-treated cells from 30% to approximately 65% of control levels (data not shown), complete restoration of this metastatic property was not realized suggesting that other signaling pathways contributing to cell invasion are also impacted by miR-146. In this regard, it is noteworthy that epidermal growth factor receptor (EGFR), as a predicted target of miR-146 (miRGen database), coupled with the use of 10 ng/ml EGF as chemoattractant in the cell-invasion assays, is such a candidate pathway potentially impacted by miR-146 expression in MDA-MB-231 cells. Given the multiplicity of signals the aberrant regulation of which could provide a cancer cell with constitutively active NF-kB, it was perhaps surprising that expression of miR-146a/b in the highly metastatic human breast cancer cell line MDA-MB-231 produced suppression of NF-kB activity, although many tumor cells express IL-1 and Toll-like receptors (Singer et al., 2003; Merrell et al., 2006) and are thus potentially vulnerable to IRAK1 and TRAF6 suppression. MDA-MB-231 cells, in particular, have been shown to express the IL-1 receptor as well as Toll-like receptors 4 and 9 (Singer et al., 2003; Merrell et al., 2006) . Future studies evaluating the susceptibility of various other cancer cell lines and tumors with constitutively active NF-kB programs to modulation by miR-146a/b expression will likely provide deeper insights and therapeutic opportunities for treating metastatic disease, a problem that has remained largely intractable. Cells were plated in triplicate at 1 Â 10 5 cells per insert in DMEM media with 10 ng/ml recombinant EGF in DMEM media used as the chemoattractant in the lower chambers for both invasion and migration assays. Following 20 h of incubation, inserts were processed according to the manufacturer's recommendations using 1% Toluidine Blue. Stained membranes were photographed using an Olympus I Â 70 microscope at Â 70. b Quantification of invasion achieved by the miR-146a and miR-146b cells as a percentage of that achieved by control cells. Cell counts were determined from the average of five random fields (each field capturing approximately 6% of total membrane area). (c) Quantification of migration through 8-mm pore inserts (BD Biosciences) by miR-146a-and miR-146b-expressing cells as a percentage of that achieved by control cells. All cell-invasion and migration assays were repeated in three independent experiments using the lentiviral-infected miR-146a, miR-146b and control cell pools. DMEM, Dulbecco's modified Eagle's medium; miR, microRNA; EGF, epidermal growth factor.
Suppression of NF-jB activity in cancer cells by miR-146
D Bhaumik et al
